Net Cash Provided by (Used in) Financing Activities in USD of Predictive Oncology Inc. from 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Predictive Oncology Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2024.
  • Predictive Oncology Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was -$112K.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $149K, a 97.8% decline from 2022.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.72M, a 86.7% decline from 2021.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $50.3M, a 289% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$112K -$112K 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024
Q1 2023 $0 -$86.9K -100% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $86.9K -$30.2M -99.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $30.3M +$24.4M +413% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q1 2020 $5.91M +$2.28M +62.6% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q1 2019 $3.64M +$621K +20.6% 01 Jan 2019 31 Mar 2019 10-Q 08 Jun 2020
Q1 2018 $3.02M -$800K -21% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q1 2017 $3.81M 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q1 2013 $1.3M +$1.15M +769% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013
Q1 2012 $150K -$540K -78.3% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q1 2011 $689K 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012

Predictive Oncology Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $149K -$6.57M -97.8% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 $6.72M -$43.6M -86.7% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $50.3M +$37.4M +289% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023
2020 $13M +$3.63M +39% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $9.32M +$3.53M +60.8% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $5.79M +$680K +13.3% 01 Jan 2018 31 Dec 2018 10-K 01 Apr 2020
2017 $5.11M +$3.4M +199% 01 Jan 2017 31 Dec 2017 10-K/A 02 Apr 2019
2016 $1.71M 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2012 $1.07M -$821K -43.3% 01 Jan 2012 31 Dec 2012 10-K 22 Mar 2013
2011 $1.9M +$1.08M +133% 01 Jan 2011 31 Dec 2011 10-K 22 Mar 2013
2010 $813K 01 Jan 2010 31 Dec 2010 10-K 16 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.